JBSS revenue holds up, but recall and factory costs crater quarterly EPS

The market expected roughly an in-line quarter on sales and about $1.17 of EPS. Published estimates were approximately $280.37 million of revenue and $1.17 of EPS; revenue essentially matched, but reported EPS was far below that benchmark.

The top line held up, but the earnings engine deteriorated sharply. Net sales rose 4.2%, supported by 2.8% pricing and 1.4% volume growth. Gross profit fell 9.5%, while gross margin dropped from 18.1% to 15.7% (Gross Profit), making the revenue result effectively irrelevant to the quarter’s earnings outcome.

The miss was driven by identifiable costs, but they were broader than the recall alone. The filing cites $2.7 million of recall-related costs, higher customer claims, snack-bar ingredient costs, freight, and manufacturing inefficiencies tied to onboarding a large contract customer. Operating expenses also increased to 11.3% of sales from 10.6% (Operating Expenses, net), so the pressure hit both gross margin and below-gross-profit spending.

Volume turning positive is encouraging, but the quality of growth remains mixed. Company-wide volume rose 1.4% after five consecutive quarters of decline. 〔0〕 However, consumer volume increased only 0.8%, commercial ingredients fell 5.4%, and contract manufacturing growth of 12.6% was largely tied to a significant new customer (Sales Volume). That means the recovery is not yet broad-based, while customer onboarding is simultaneously creating execution costs.

The full-year result does not offset the weak exit. Fiscal-year sales rose 6.2% and diluted EPS increased 4.6% to $5.26, but full-year volume fell 2.5% and gross margin slipped from 18.4% to 18.0% (Full Year Results). The company also announced a 5.6% increase in its annual dividend and a 75% increase in the special dividend to $1.05 per share (CEO Commentary), which supports the capital-return story but does not repair the quarter’s substantial earnings miss.